Thực trạng sử dụng kháng sinh trong điều trị viêm phổi mắc phải tại cộng đồng ở trẻ em từ 2 tháng đến 5 tuổi tại Bệnh viện Sản Nhi Nghệ An năm 2022

Abstract

Objective: To describe the use of antibiotics in the treatment of community-acquired pneumonia in children aged two months to 5 years at the Respiratory Department of Nghe An Obstetrics and Pediatrics Hospital in 2022. Subject and method: A cross-sectional study was retrospectively conducted on 215 medical records of inpatients at the Respiratory Department, with discharge dates from October 1, 2022, to December 31, 2022. Result: Among 215 patients, 87% were diagnosed with pneumonia, and 13% had severe pneumonia. Comorbidities were primarily related to the upper respiratory tract. 47% of the patients had used antibiotics before being hospitalized. Microbiological tests through nasopharyngeal fluid were indicated in 6% of the patients. Third-generation cephalosporins were the primary antibiotic used in the initial treatment protocol, and 94.4% of the initial treatment protocols complied with recommendations. Carbapenem + vancomycin was the primary alternative protocol (28.5%). Two patients with impaired renal function were treated with higher doses than recommendations. 98.6% of patients recovered and improved symptoms when being discharged. Conclusion: Third-generation cephalosporins were the most commonly prescribed antibiotics to initially treat community-acquired pneumonia. Doses for patients with impaired renal function should be adjusted carefully to ensure safety